Comparison of Synchrony Between 4 NIV Ventilators

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Prof. Philippe Jolliet, University of Lausanne Hospitals
ClinicalTrials.gov Identifier:
NCT01615432
First received: June 6, 2012
Last updated: May 15, 2013
Last verified: May 2013
  Purpose

Comparison of the effects of 4 ventilators dedicated to NIV (2 home ventilators and 2 ventilators designed for NIV) on patient-ventilator synchrony and comfort in patients admitted in the intensive care unit for respiratory failure and treated with NIV.


Condition Intervention
Respiratoy Failure Requiring NIV Treatment
Device: V-PAP III ventilator
Device: Stellar 150 ventilator
Device: BiPAP vision ventilator
Device: V60 ventilator

Study Type: Interventional
Study Design: Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Comparison of Four Different Ventilators for Noninvasive Ventilation in Terms of Patient-ventilator Synchrony and Comfort

Further study details as provided by University of Lausanne Hospitals:

Primary Outcome Measures:
  • Patient-ventilator synchrony [ Designated as safety issue: No ]
    Patient-ventilator synchrony will be assessed breath by brath on the basis of airway pressure, flow and diaphragmatic electrical activity recordings.


Secondary Outcome Measures:
  • comfort of patient under NIV [ Designated as safety issue: No ]
    Patient's confort during NIV will be assessed using a visual analogic scale.

  • Ventilatory parameters [ Designated as safety issue: No ]
    Tidal volume, respiratory rate, inspiratory time, expiratory time and maximal and mean airway pressure will be measured from the continuous recording of airway pressure and flow.


Enrollment: 22
Study Start Date: June 2012
Study Completion Date: April 2013
Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • respiratory failure

Exclusion Criteria:

  • Severe hypoxemia requiring an FiO2 > 0.6
  • Hemodynamic instability : defined as a variation of > 20% in mean arterial pressure (MAP) and heart rate (HR) during the previous 2 hours; the need for high doses of catecholamines (namely > 0.5 mcg/kg/min) and/or the need of major volume resuscitation (more than 2 liters of fluids in 2 hours)
  • Impaired consciousness or absence of patient cooperation;
  • Facial or laryngeal lesions contraindicating the use of NIV;
  • Poor short term prognosis.
  • Age < 18 years old
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01615432

Locations
Switzerland
Intensive care and burn unit / CHUV
Lausanne, Vaud, Switzerland, 1011
Sponsors and Collaborators
University of Lausanne Hospitals
  More Information

No publications provided

Responsible Party: Prof. Philippe Jolliet, Main investigator, University of Lausanne Hospitals
ClinicalTrials.gov Identifier: NCT01615432     History of Changes
Other Study ID Numbers: Synchro_Non invasive vent
Study First Received: June 6, 2012
Last Updated: May 15, 2013
Health Authority: Switzerland: Laws and standards
Switzerland: Ethikkommission

ClinicalTrials.gov processed this record on October 20, 2014